< > W348 - Merial Animal Health Ltd - http://www.merial.com

General Information

Please note:

  • This hyperlink was operational at time of referencing this website.
  • The hyperlink will only work when you are "on-line".
  • Information on the Internet changes frequently and this reference relates only to the data drawn down from the internet on the date in the reference suffix (e.g. W1.May00)
Organisation Reference Merial Animal Health Ltd 
Wildpro Referenced Responsibilities:- Conventions, Legislation, Codes of Conduct, Manuals --

Merial Animal Health Ltd supports the work of the Wildlife Information Network and disseminates information on the health and management of captive and free-ranging wild animals through an Institutional Subscription to Wildpro Multimedia.


This information has been taken directly from the Merial Website:

Merial is the world's leading and most successful animal health company producing a wide range of pharmaceuticals and vaccines to keep livestock and pets healthy and productive.

An innovation-driven leader, Merial has the largest research & development investment in the animal health industry with seventeen research and development centres around the world. Merial is committed to developing pharmaceuticals and vaccines with the highest level of quality, safety and efficacy through an extensive network of sixteen manufacturing sites globally.

Headquartered in the UK, with operations based in the US, France, Latin America and Asia, Merial employs approximately 6,500 people, operates in more than 150 countries and generates sales in excess of $1.7 billion Euros.


Merial's worldwide network of manufacturing sites provides the global market with competitive solutions.

Proximity to customers ensures a steady supply of safe, high-quality products whenever and wherever needed. Our strong production capability enables us to supply millions of doses of vaccines in a matter of days when epidemics strike - and to keep veterinarians, food animal producers and farmers everywhere supplied with the products they need.

Merial around the world:

Merial meets the needs of global markets through an extensive network of over 20 manufacturing sites worldwide, placing our sales and distribution capabilities in close proximity to all of our customers.


One of the largest Research & Development investment in the animal health industry, and a worldwide network of laboratories, enable Merial to achieve continuous innovation in animal healthcare.

Highly-focused R&D personnel and programmes enable us to anticipate and respond to the needs of a rapidly-changing animal health industry.

Merial's R&D benefits from full access to the extensive research resources of our parent companies (Merck & Co. Inc, and Aventis S.A.)- two of the world's leading life science companies.


One of Merial's most powerful resources is its rich and exciting pipeline on which the company's strength and future growth are being built.

Merial's research philosophy emphasises the development of new products to enhance the health and performance of all livestock and companion animal species and to protect against parasitic, enteric and respiratory diseases in bovine, porcine and companion animal species.

Research programmes specifically dedicated to avian species are also in development.

Epidemiological Surveillance:

Merial is commited to effective epidemiological surveillance. By helping to develop and enforce international policies and regulations regarding animal health and welfare, Merial actively participates in the fight against major epidemics throughout the world. When new strains of viruses appear, Merial research teams react rapidly and effectively, developing the powerful new vaccines needed to fight them.

Merial is the worldwide leader in animal health. We take our responsibilities seriously recognizing that the invention of effective animal health products has not only made the prevention and care of animal disease possible, but also protects the health and well-being of man. 

Dates Referenced June 2002
Contact Details

For media enquiries at Merial corporate communications:

Worldwide Headquarters
Margaret Morgan
27 Knightsbridge
London SW1X 7QT
Tel: (44) 020 7591 7400
Fax: (44) 020 7591 7401

Asian Headquarters
Anne-Lise St-Gerand
57A The Faraday
Science Park Drive
Singapore Science Park
Tel: (65) 77 85977
Fax: (65) 77 66903

European Headquarters
Jean-Charles Merlo
Amanda Evans-Verfay
29 avenue Tony Garnier
69007 Lyon
Tel: (33) 4 7272 3000
Fax: (33) 4 7272 3069 

North American Headquarters
Jane Calloway
3239 Satellite Boulevard
Duluth, Georgia 30096-4640 
Tel: (1) 678 638 3000
Toll Free: (888) 637-4251 

South American headquarters
Cristiano Simson
Av. Luis Carlos Berrini, 1297
5 andar, Conj. 52
CEP 04571-010
São Paulo SP
Tel: (55) 11 5505 9092
Fax: (55) 11 5505 9093 

Website Address

http://www.merial.com and http://uk.merial.com



Return to top of page

Specific References (Please note - website addresses change frequently and all references are dated accordingly. If hyperlinks are no longer active, please inform us)

Reference Section of Website Specific Website link
W348.20Jan03.wnv1 News Release: Merial Introduces Next Generation Equine West Nile Virus Vaccine. January 8, 2004 http://us.merial.com/merial_corporate/news/press_releases/01-07-2004_WNV_Product_Announcement.asp
W348.Apr05.w1 Ketofen - More gain with less pain http://uk.merial.com/pdf/literature/ketofendairy_more_gain_less_pain.pdf

Return to top of page